MondayJan 11, 2021 12:03 pm

CannAssist International Corp.’s (CNSC) Proprietary Technology Offers Superior Absorption, Efficacy

Imperial College of London review suggests that cannabis-based medicinal products offer significant relief from intractable epilepsy CNSC produces proprietary CBD products under the Xceptol brand that are created with branded Technology CiBiDinol that increases absorbability, bioavailability, shelf life Third-party Xceptol testing shows 300% increased gut absorption, 400% increased skin penetration when compared to mainstream CBD oil products Researchers from the Imperial College of London recently conducted a review that examined the impact of cannabis-based medicinal products containing cannabidiol (“CBD”) on the frequency of epileptic seizures and determined that they offer patients significant relief from intractable epilepsy (https://cnw.fm/XL0hJ). As scientific evidence supporting…

Continue Reading

ThursdayJan 07, 2021 1:10 pm

CannAssist International Corp. (CNSC) Flagship Brand Approved, Included by Powerful Online Platform

Acceptance of Xceptol products on RangeMe website new revenue source, increasing SKUs and access to retailers RangeMe enables retail buyers to discover innovative, emerging products; empowers suppliers to manage, grow their brands CannAssist developed Xceptol brand to offer effective health and wellness solutions without side effects CannAssist International (OTCQB: CNSC) has announced that its flagship brand — Xceptol — has been approved and included by the distribution website RangeMe (https://www.cnw.fm/vRWf4). Xceptol's inclusion on the website means increasing SKUs, access to more than 10,000 retailers, and a significant new revenue source for CNSC. "This is exciting news for us on many fronts,"…

Continue Reading

WednesdayJan 06, 2021 2:02 pm

Pure Extracts Technologies (CSE: PULL) Draws Out Expansion Plans in Anticipation of Regulatory Changes Within Mushroom Sector

Pure Extracts Technologies Corp. has announced plans to expand, build fourth unit in dedicated towards research, development of psilocybin Announcement on its expansion plans come shortly after the Company revealed it plans to apply to Health Canada for a Dealer’s License Award of Dealer’s License would allow Pure Extracts to cultivate, harvest and procure controlled substances and carry out research into psychedelic compounds such as psilocybin and psilocin – paving way towards future commercialization of its product The Dealer’s License application has taken on increased relevance following Health Canada’s decision to revise existing regulations to permit certain authorized uses of…

Continue Reading

WednesdayJan 06, 2021 12:57 pm

CannAssist International Corp.’s (CNSC) Proprietary CiBiDinol Technology Promises to Outperform Conventional CBD Oil for Superior Pain-Relief

Market for CBD-based pain relief products is growing rapidly, projected to reach $20 billion by 2024 CNSC is a biotech company that produces fast-acting CBD products under the Xceptol brand Xceptol products are formulated with exclusive technology that increases absorbability, bioavailability, shelf life Third-party testing on Xceptol suggests 400% increase in skin penetration, 300% increase in gut absorption when compared to regular oil-based CBD CannAssist International (OTCQB: CNSC), owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company marketing the Xceptol consumer brand - a line of cannabidiol (“CBD”) products that promises increased absorption, bioavailability and longer shelf life.…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722